Format

Send to

Choose Destination
Exp Mol Med. 2016 Nov 25;48(11):e272. doi: 10.1038/emm.2016.103.

Aldehyde dehydrogenase is used by cancer cells for energy metabolism.

Author information

1
Cancer Cell and Molecular Biology Branch, National Cancer Center, Research Institute, Goyang, Gyeonggi-do, Republic of Korea.
2
Cancer Immunology Branch, National Cancer Center, Research Institute, Goyang, Gyeonggi-do, Republic of Korea.
3
Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Republic of Korea.
4
Department of Biological Chemistry, University of Science and Technology, Daejeon, Republic of Korea.
5
Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Genomic Instability Research Center, Suwon, Korea.
6
Department of Biomedical Sciences, The Graduate School, Ajou University, Suwon, Korea.
7
Omics Core Laboratory, National Cancer Center, Research Institute, Goyang, Republic of Korea.

Abstract

We found that non-small-cell lung cancer (NSCLC) cells express high levels of multiple aldehyde dehydrogenase (ALDH) isoforms via an informatics analysis of metabolic enzymes in NSCLC and immunohistochemical staining of NSCLC clinical tumor samples. Using a multiple reaction-monitoring mass spectrometry analysis, we found that multiple ALDH isozymes were generally abundant in NSCLC cells compared with their levels in normal IMR-90 human lung cells. As a result of the catalytic reaction mediated by ALDH, NADH is produced as a by-product from the conversion of aldehyde to carboxylic acid. We hypothesized that the NADH produced by ALDH may be a reliable energy source for ATP production in NSCLC. This study revealed that NADH production by ALDH contributes significantly to ATP production in NSCLC. Furthermore, gossypol, a pan-ALDH inhibitor, markedly reduced the level of ATP. Gossypol combined with phenformin synergistically reduced the ATP levels, which efficiently induced cell death following cell cycle arrest.

PMID:
27885254
PMCID:
PMC5133370
DOI:
10.1038/emm.2016.103
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center